Evidence map›Paper›PMID 41685361›Full record

ArticleMaterials today. Bio2026

Bridging traditional Chinese medicine theory with advanced MOFs delivery for synergistic drug-resistant infected-chronic wound therapy.

Chen Chen, Na Zhang, Fructueux Modeste Amona, Xiaolei Han, Qi Tang, Lanxin Geng, Guangfu Liao, Jie Zhang, Tushuai Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chen ChenCollege of Hydraulic Engineering, Jiangsu Vocational Institute of Architectural Technology, Xuzhou, Jiangsu, 221000, China.
Na ZhangSchool of Food and Biological Engineering, Xuzhou University of Technology, Xuzhou, Jiangsu, 221018, China.
Fructueux Modeste AmonaInstitute of Cellular and Molecular Biology, School of Life Science, Jiangsu Normal University, Xuzhou, Jiangsu, 221116, China.
Xiaolei HanSchool of Biology and Food Engineering, Suzhou University of Technology, Suzhou, Jiangsu, 215500, China.
Qi TangSchool of Biology and Food Engineering, Suzhou University of Technology, Suzhou, Jiangsu, 215500, China.
Lanxin GengSchool of Biology and Food Engineering, Suzhou University of Technology, Suzhou, Jiangsu, 215500, China.
Guangfu LiaoCollege of Materials Engineering, Fujian Agriculture and Forestry University, Fuzhou, 350002, China.
Jie ZhangSchool of Biology and Food Engineering, Suzhou University of Technology, Suzhou, Jiangsu, 215500, China.
Tushuai LiSchool of Biology and Food Engineering, Suzhou University of Technology, Suzhou, Jiangsu, 215500, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic wounds infected with multidrug-resistant bacteria pose a significant challenge to global health, as traditional monotherapies often fail to eradicate pathogens and restore the damaged wound microenvironment. Engineering innovative nanocomposites that integrate synergistic therapeutics and controlled release is a pivotal strategy for advanced wound management. Here, we developed a novel multi-drug metal-organic framework (MOF) nanocomposite, BBR + FA@UiO, by covalently grafting ferulic acid (FA) onto UiO-66-NH

Indexed as

Infected chronic wound healingMetal-organic frameworksROS scavengingStimuli-responsive drug releaseSynergistic antibacterial therapyTraditional Chinese medicine

Identifiers

PMID41685361
PMCPMC12890853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.